CSD PHARMA CONSULTING LTD

Company number 08725656 ·

Active

Net assets, total assets & total liabilities 2016 – 2025

  • Total assets
  • Net assets
  • Total liabilities
-£100k -£50k £0 £50k £100k £150k £200k £250k 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Total assets 2016: £27,044 Total assets 2017: £24,860 Total assets 2018: £36,736 Total assets 2019: £2,251 Total assets 2020: £2,353 Total assets 2021: £7,103 Total assets 2022: £23,838 Total assets 2023: £17,731 Total assets 2024: £74,193 Total assets 2025: £210,979 Total assets Net assets 2016: £118 Net assets 2017: £185 Net assets 2018: £107 Net assets 2019: £186 Net assets 2020: £844 Net assets 2021: £5,107 Net assets 2022: £19,117 Net assets 2023: £15,383 Net assets 2024: £31,397 Net assets 2025: £127,537 Net assets Total liabilities 2016: -£26,926 Total liabilities 2017: -£24,675 Total liabilities 2018: -£36,629 Total liabilities 2019: -£2,065 Total liabilities 2020: -£1,509 Total liabilities 2021: -£1,996 Total liabilities 2022: -£4,721 Total liabilities 2023: -£2,348 Total liabilities 2024: -£42,796 Total liabilities 2025: -£83,442 Total liabilities

Figures extracted from filed accounts. Hover a point for the exact value.

Employees 2024 – 2025

0 0 0 0 0 1 2024 2025 2024: 1 2025: 1

Average employees, from filed accounts. Hover a point for the exact figure.

Balance sheet by year 12 years

Latest accounts (2025-10-31): Audit exempt.

Year ending Total assets Total liabilities Net assets Cash Turnover Profit Employees
2025-10-31 £210,979 -£83,442 £127,537 £202,036 1
2024-10-31 £74,193 -£42,796 £31,397 £73,622 1
2023-10-31 £17,731 -£2,348 £15,383 £17,479
2022-10-31 £23,838 -£4,721 £19,117 £23,646
2021-10-31 £7,103 -£1,996 £5,107 £6,816
2020-10-31 £2,353 -£1,509 £844 £2,125
2019-10-31 £2,251 -£2,065 £186 £1,910
2018-10-31 £36,736 -£36,629 £107 £12,502
2017-10-31 £24,860 -£24,675 £185 £24,163
2016-10-31 £27,044 -£26,926 £118 £12,689
2015-10-31 £51,787 -£25,503 £26,493 £31,964
2014-10-31 £29,546 -£29,363 £277 £9,414

Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.